Relief of intractable pruritus after administration of botulinum toxin a (Botox): A case report

Clinical Neuropharmacology

Volumn 31, Issue 5, 2008, Pages 303-306

  Salardini, Arash ^a   Richardson, Dianna ^a   Jabbari, Bahman ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin A (Botox); Itch; Pruritis

Indexed keywords

ANTIPRURITIC AGENT; BOTULINUM TOXIN A; GABAPENTIN; LOCAL ANESTHETIC AGENT; PROCAINE;

ADULT; ARTICLE; CASE REPORT; DISEASE DURATION; FEMALE; FOREHEAD; FRONTAL BONE; FRONTAL SINUS; HUMAN; LOCAL ANESTHESIA; PRIORITY JOURNAL; PRURITUS; SKIN SENSATION; SKIN TINGLING; SKULL SURGERY; INTRAMUSCULAR DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

BOTULINUM TOXIN TYPE A; FEMALE; FOREHEAD; HUMANS; INJECTIONS, INTRAMUSCULAR; PRURITUS;

EID: 65849346711     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181672225     Document Type: Article

References (25)

1. Merriam-Webster's Medical Desk Dictionary. Springfield, MA: Merriam-Webster Inc; 2006.
2. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM 2003;96: 7-26.
3. Blersch W, Schulte-Mattler WJ, Przywara S, et al. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomised study. J Neurol Sci 2002;205:59-63.
4. Greene P, Kang U, Fahn S, et al. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990;40:1213.
5. Abbott JA, Jarvis SK, Lyons SD, et al. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006;108:915-923.
6. Babcock MS, Foster L, Pasquina P, et al. Treatment of pain attributed to plantar fasciitis with botulinum toxin A: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 2005;84:649-654.
7. Foster L, Clapp L, Erickson M, et al. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001;56: 1290-1293.
8. Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX® Migraine Clinical Research Group. Headache 2000;40:445-450.
9. Park HJ, Lee Y, Lee J, et al. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006;53: 470-477.
10. Cui M, Khanijou S, Rubino J, et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107:125-133.
11. Bach-Rojecky L, Relja M, Lackovi( Z. Botulinum toxin type A in experimental neuropathic pain. J Neural Transm 2005;112(2):215-219.
12. Voller B, Sycha T, Gustorff B, et al. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology 2003;61: 940-944.
13. Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17(20):8003-8008.
14. Schmelz M, Hilliges M, Schmidt RO, et al. Active itch fibres in chronic pruritus. Neurology 2003;26: 564-566.
15. Andrew D, Craig AD. Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001;4: 72-77.
16. 2O positron emission tomography studies. Pain 2001;92(1-2):295-305.
17. Greaves MW, Wall PD. Pathophysiology of itching. Lancet 1996;348(9032):938-940.
18. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003;361:690-694.
19. Wallengren J. Neuroanatomy and neurophysiology of itch. Dermatol Ther 2005;18(4):292-303.
20. Colvin LA, Power I. Neurobiology of chronic pain states. Anaesth Intensive Care Med 2005;6(1): 10-13.
21. Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon 2000; 38:245-258.
22. Rand MJ, Whaler BC. Impairment of sympathetic transmission by botulinum toxin. Nature 1965;206: 588-591.
23. Filippi GM, Errico P, Santarelli R, et al. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113(3):400-404.
24. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005;26(5): 785-793.
25. Heckmann M, Heyer G, Brunner B, et al. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol 2002;46(4):617-619.